JENNIFER CURRO: Open Payments
NPI 1639683972 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,208 in 28 payments from 14 companies in 2025. Trend: 2023 $568 · 2024 $1,150 · 2025 $2,208
Food & beverage: $2,208
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $488 |
| Novo Nordisk Inc | 7 | $363 |
| Pharming Healthcare, Inc. | 1 | $160 |
| Galderma Laboratories, L.P. | 1 | $150 |
| CSL Behring | 1 | $125 |
| ViiV Healthcare Company | 1 | $125 |
| GENZYME CORPORATION | 1 | $124 |
| SANOFI US SERVICES INC. | 1 | $120 |
| C2N Diagnostics, LLC | 1 | $118 |
| Optinose US, Inc. | 1 | $111 |
Products named: AIRSUPRA, Ozempic, RUCONEST, NEMLUVIO, Wegovy, Andembry, APRETUDE, DUPIXENT.
Industry payments across FL — which companies pay providers there.
